AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer

This publication has 28 references indexed in Scilit:

• Loss of ERβ expression as a common step in estrogen-dependent tumor progression
  Endocrine-Related Cancer, 2004
• Human Type 3 3α-Hydroxysteroid Dehydrogenase (Aldo-Keto Reductase 1C2) and Androgen Metabolism in Prostate Cells
  Endocrinology, 2003
• Current molecular aspects of the carcinogenesis of the uterine endometrium
  International Journal of Gynecologic Cancer, 2001
• Role of Exogenous and Endogenous Hormones in Endometrial Cancer
  Annals of the New York Academy of Sciences, 2001
• Hormones and Hormone Antagonists: Mechanisms of Action in Carcinogenesis of Endometrial and Breast Cancer
  Hormone and Metabolic Research, 2001
• Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome
  Cancer Letters, 2001
• A guide to 17β-hydroxysteroid dehydrogenases
  Molecular and Cellular Endocrinology, 2001
• Hormonal carcinogenesis
  Carcinogenesis: Integrative Cancer Research, 2000
• Differential expression of 17beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines
  Journal of Molecular Endocrinology, 2000
• Characteristics of a Highly Labile Human Type 5 17 -Hydroxysteroid Dehydrogenase
  Endocrinology, 1999